Transradial artery access on the rise affects global market for vascular closure devices through 2015

According to a new report by Life Science Intelligence the global market for vascular closure devices will exceed US$800 million by 2015. However, its growth will be limited by an increased use of transradial artery access and manual compression procedures.

Two new clinical studies to evaluate the Symplicity renal denervation system for different conditions

On 13 February, Medtronic launched two clinical studies to evaluate the use of its Symplicity renal denervation system for treatment-resistant hypertension across different conditions in a real-world setting.

Renal denervation “represents a great opportunity to make a difference”

At the ISET conference in January in Miami, USA, Horst Sievert, CardioVascular Center Frankfurt, Frankfurt, Germany, told delegates why he believes that renal denervation could become as important as percutaneous coronary intervention or percutaneous transluminal angioplasty. “I believe that renal denervation represents a great opportunity for interventionalists to make a difference,” he said.

Symplicity Renal Denervation System receives Health Canada licence

Medtronic has announced that it has received a Health Canada licence for its Symplicity Renal Denervation System to reduce treatment-resistant high blood pressure in patients unresponsive to three or more anti-hypertensive medications.

Interventional Radiologists Fight Post-Thrombotic Syndrome, Provide Hope For Chronic DVT

Bard’s Fluency Plus Shows Effectiveness in Treatment of Dysfunctional AV Access Circuits

In the Journal of Vascular and Interventional Radiology, Bart L. Dolmatch, MD, et al published findings from a study using the Fluency Plus stent graft (Bard Peripheral Vascular, Tempe, AZ) to review technical and 180-day clinical outcomes in the treatment of dysfunctional arteriovenous (AV) hemodialysis access circuits (2012;23:479-487).

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

Six Month Pooled Outcomes From Randomized and Crossover Patients Following Renal Denervation Presented at the 22nd Annual Scientific Meeting of the European Society of Hypertension Confirm Previous Symplicity Clinical Trial Findings

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon (DEB) Study

First Patients Treated in Clinical Trial of Novel Medical Device Involving Interventions for Lower-Extremity Peripheral Artery Disease

Nordion announces Europe-focused phase III clinical trial for TheraSphere liver cancer treatment

The study will evaluate and compare safety and efficacy of TheraSphere vs sorafenib in hepatocellular carcinoma patients with portal vein thrombosis

The European Conference on Interventional Oncology (ECIO) goes annual

The European Conference on Interventional Oncology (ECIO) has announced that the meeting will become an annual event as of 2012.

Microsulis Medical establishes strategic relationship with AngioDynamics

Microsulis Medical has announced a multi-faceted strategic relationship with AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology.

Visual-ICE Cryoablation System gets FDA clearance

The US Food and Drug Administration has given 510(k) clearance to Galil Medical to market its Visual-ICE Cryoablation System.

SIR-Spheres microspheres safe to treat metastatic liver tumours in patients who failed systemic chemotherapy

SIR-Spheres microspheres (Sirtex) are safe and provide clinical benefit for patients with colon cancer liver metastases who have previously received liver-directed and systemic chemotherapy, according to the results of a prospective clinical study presented at the Society of Interventional Radiology (SIR) Annual Scientific Meeting (March 24–29, San Francisco, USA).

Percutaneous IRE feasible and safe for locally advanced pancreatic adenocarcinoma

The results of a study presented at the Society of Interventional Radiology’s 37th Annual Scientific Meeting in San Francisco, USA, provide hope for individuals with inoperable locally advanced pancreatic cancer (LAPC). Irreversible electroporation has been successful in treating primary and metastatic liver cancer and is now in the first stages of implementation as a treatment for pancreatic cancer.

Cryoablation controls metastatic breast cancer with less pain and no major complications

Percutaneous cryoablation could potentially be used as a last line of defense to halt individual spots of remaining metastatic breast cancer by freezing and destroying tumours, according to study presented at the Society of Interventional Radiology’s 37th Annual Scientific Meeting in San Francisco, USA.